Skip to main content
Clinical Trials/NCT02110693
NCT02110693
Completed
Not Applicable

The TAPS Tool: Screen and Brief Assessment Tool Validation Study

Friends Research Institute, Inc.4 sites in 1 country2,057 target enrollmentMarch 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use Disorder
Sponsor
Friends Research Institute, Inc.
Enrollment
2057
Locations
4
Primary Endpoint
Diagnostic and Statistical Manual-5 (DSM-5) Alcohol Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of the study is to develop and validate a questionnaire to screen and assess adult primary care patients for tobacco, alcohol, prescription drug, and drug use and problems related to their use.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
April 2015
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Primary care patients
  • Able to provide informed consent

Exclusion Criteria

  • inability to comprehend spoken English
  • inability to self-administer the instrument on the tablet computer due to physical limitations
  • previously enrolled in the study

Outcomes

Primary Outcomes

Diagnostic and Statistical Manual-5 (DSM-5) Alcohol Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview

Time Frame: Baseline

The Modified World Mental Health Composite International Diagnostic Interview is a structured interview that assesses whether or not the participant meets DSM-5 Diagnostic Criteria

Diagnostic and Statistical Manual DSM-5 Diagnosis of Heroin Use Disorder Measured by the The Modified World Mental Health Composite International Diagnostic Interview

Time Frame: Baseline

The Modified World Mental Health Composite International Diagnostic Interview is a structured interview that assesses whether or not the participant meets DSM-5 Diagnostic Criteria

Diagnostic and Statistical Manual DSM-5 Diagnosis of Tobacco Use Disorder Measured by the Modified World Mental Health Composite International Diagnostic Interview

Time Frame: Baseline

The Modified World Mental Health Composite International Diagnostic Interview is a structured interview that assesses whether or not the participant meets DSM-5 Diagnostic Criteria

Diagnostic and Statistical Manual-5 (DSM-5) Cannabis Use Disorder Diagnosis Measured With Modified World Mental Health Composite International Diagnostic Interview

Time Frame: Baseline

The Modified World Mental Health Composite International Diagnostic Interview is a structured interview that assesses whether or not the participant meets DSM-5 Diagnostic Criteria

Diagnostic and Statistical Manual-5 (DSM-5) Cocaine and Amphetamine (Stimulant) Use Disorder Diagnosis Measured by the Modified World Mental Health Composite International Diagnostic Interview

Time Frame: Baseline

The Modified World Mental Health Composite International Diagnostic Interview is a structured interview that assesses whether or not the participant meets DSM-5 Diagnostic Criteria

Secondary Outcomes

  • High Risk Tobacco Use Measured by the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST)(Baseline)
  • Risky Alcohol Use(Baseline)
  • Cigarette Smoking Risk(baseline)
  • Smokeless Tobacco Questionnaire(baseline)
  • Unhealthy Cannabis Use(Baseline)
  • Cannabis Positive Oral Fluid Test(baseline)

Study Sites (4)

Loading locations...

Similar Trials